Friday, July 26, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Congress Orders Research to Assess COVID Shot Injuries Among U.S. Military Personnel

Congress Orders Research to Assess COVID Shot Injuries Among U.S. Military Personnel

In the National Defense Authorization Act (NDAA) for fiscal year 2024, the U.S. Congress is requiring the U.S. Department of Defense (DoD) to study and report on poor health conditions that active duty members of the Armed Forces developed after administration of COVID-19 shots.1 The NDAA was passed in late 2023 and calls for “a […]

U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic

U.S. Government Gives Moderna 6 Million to Develop mRNA Bird Flu Biologic

On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 avian influenza biologic labeled a “vaccine,” as the media reports concerns about bird flu in dairy cows and farm workers in multiple states. The funds from the U.S. Biomedical Advanced Research and Development […]

More Parents in U.K. Refuse Childhood Vaccinations

More Parents in U.K. Refuse Childhood Vaccinations

In late 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that there had been a decline in state required vaccines from 95 percent to 93 percent among kindergarteners during the 2020-2021 school year compared to the 2019-2020 school year.1 2 Now, public health officials in the United Kingdom also are reporting lower […]

Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial

Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial

Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]

FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine

FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine

On June 17, 2024, the U.S. Food and Drug Administration (FDA) licensed Merck & Company, Inc.’s new pneumococcal conjugate vaccine Capvaxive (formerly V116) for adults 18 years of age and older. The vaccine is designed to protect against 21 types of the bacteria causing pneumococcal disease, which can lead to severe infection in the lungs […]

Finland Offers Bird Flu Vaccine to Farm Workers

Finland Offers Bird Flu Vaccine to Farm Workers

Public health officials in Finland are preparing to offer H5N1 influenza (also known as avian influenza or bird flu) vaccines to people at who they believe are at risk of exposure to an avian influenza strain spreading among farmed and wild animals. Finland is the first country to administer avian influenza vaccines to certain populations […]

Search in Site

To search in site, type your keyword and hit enter

Search